Reduced immune reaction prevents immunopathology after challenge with avian influenza virus: A transcriptomics analysis of adjuvanted vaccines

Vaccine

Volumn 28, Issue 38, 2010, Pages 6351-6360

  Reemers, Sylvia S ^a   Jansen, Christine ^a   Koerkamp, Marian J Groot ^b   van Haarlem, Daphne ^a   van de Haar, Peter ^a   Degen, Winfried G J ^c   van Eden, Willem ^a   Vervelde, Lonneke ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c INTERVET INTERNATIONAL BV   (Netherlands)

Author keywords

Avian influenza virus; Microarray; Vaccination

Indexed keywords

ALUMINUM HYDROXIDE; AVIAN INFLUENZA VACCINE; CPG OLIGODEOXYNUCLEOTIDE; IMMUNOLOGICAL ADJUVANT; VIRUS RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ARTICLE; AVIAN INFLUENZA; CHICKEN; CONTROLLED STUDY; GENE EXPRESSION PROFILING; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOPATHOLOGY; IMMUNOSTIMULATION; INFLUENZA VIRUS A H3N2; LUNG; NONHUMAN; PRIORITY JOURNAL; TRACHEA; TRANSCRIPTOMICS;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, VIRAL; CHICKENS; GENE EXPRESSION PROFILING; INFLUENZA A VIRUS, H9N2 SUBTYPE; INFLUENZA IN BIRDS; INFLUENZA VACCINES; LUNG; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; TRACHEA;

EID: 77955656854     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.06.099     Document Type: Article

References (39)

1. Aucouturier J., Dupuis L., Ganne V. Adjuvants designed for veterinary and human vaccines. Vaccine 2001, 19(17-19):2666-2672.
2. Baskin C.R., Bielefeldt-Ohmann H., Tumpey T.M., Sabourin P.J., Long J.P., García-Sastre A., et al. Early and sustained innate immune response defines pathology and death in nonhuman primates infected by highly pathogenic influenza virus. Proc Natl Acad Sci USA 2009, 106(9):3455-3460.
3. Breed D.G., Carr P., Vermeulen A.N. Differential binding of 2 monoclonal antibodies directed against the chicken CD8 alpha molecule. Vet Immunol Immunopathol 1996, 52(1-2):117-125.
4. Cameron C.M., Cameron M.J., Bermejo-Martin J.F., Ran L., Xu L., Turner P.V., et al. Gene expression analysis of host innate immune responses during lethal H5N1 infection in ferrets. J Virol 2008, 82(22):11308-11317.
5. Cillóniz C., Shinya K., Peng X., Korth M.J., Proll S.C., Aicher L.D., et al. Lethal influenza virus infection in macaques is associated with early dysregulation of inflammatory related genes. PLoS Pathog 2009, 5(10):e1000604.
6. Cox J.C., Coulter A.R. Adjuvants-a classification and review of their modes of action. Vaccine 1997, 15(3):248-256.
7. de Jong M.D., Simmons C.P., Thanh T.T., Hien V.M., Smith G.J., Chau T.N., et al. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat Med 2006, 12(10):1203-1207.
8. Degen W.G., Smith J., Simmelink B., Glass E.J., Burt D.W., Schijns V.E. Molecular immunophenotyping of lungs and spleens in naive and vaccinated chickens early after pulmonary avian influenza A (H9N2) virus infection. Vaccine 2006, 24(35-36):6096-6109.
9. Douek D.C., Roederer M., Koup R.A. Emerging concepts in the immunopathogenesis of AIDS. Annu Rev Med 2009, 60:471-484.
10. Eldaghayes I., Rothwell L., Williams A., Withers D., Balu S., Davison F., et al. Infectious bursal disease virus: strains that differ in virulence differentially modulate the innate immune response to infection in the chicken bursa. Viral Immunol 2006, 19(1):83-91.
11. Gomis S., Babiuk L., Allan B., Willson P., Waters E., Hecker R., et al. Protection of chickens against a lethal challenge of Escherichia coli by a vaccine containing CpG oligodeoxynucleotides as an adjuvant. Avian Dis 2007, 51(1):78-83.
12. Hazenberg M.D., Otto S.A., van Benthem B.H., Roos M.T., Coutinho R.A., Lange J.M., et al. Persistent immune activation in HIV-1 infection is associated with progression to AIDS. AIDS 2003, 17(13):1881-1888.
13. Hilgers L.A., Nicolas I., Lejeune G., Dewil E., Boon B. Effect of various adjuvants on secondary immune response in chickens. Vet Immunol Immunopathol 1998, 66(2):159-171.
14. Hogenesch H. Mechanisms of stimulation of the immune response by aluminum adjuvants. Vaccine 2002, 20(Suppl. 3):S34-S39.
15. Ishii K.J., Akira S. Toll or toll-free adjuvant path toward the optimal vaccine development. J Clin Immunol 2007, 27(4):363-371.
16. Jansen T., Hofmans M.P., Theelen M.J., Manders F.G., Schijns V.E. Dose and timing requirements for immunogenicity of viral poultry vaccine antigen: investigations of emulsion-based depot function. Avian Pathol 2007, 36(5):361-365.
17. Kash J.C., Basler C.F., García-Sastre A., Carter V., Billharz R., Swayne D.E., et al. Global host immune response: pathogenesis and transcriptional profiling of type A influenza viruses expressing the hemagglutinin and neuraminidase genes from the 1918 pandemic virus. J Virol 2004, 78(17):9499-9511.
18. Kash J.C., Tumpey T.M., Proll S.C., Carter V., Perwitasari O., Thomas M.J., et al. Genomic analysis of increased host immune and cell death responses induced by 1918 influenza virus. Nature 2006, 443(7111):578-581.
19. Klinman D.M., Currie D., Gursel I., Verthelyi D. Use of CpG oligodeoxynucleotides as immune adjuvants. Immunol Rev 2004, 199:201-216.
20. Kobasa D., Jones S.M., Shinya K., Kash J.C., Copps J., Ebihara H., et al. Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus. Nature 2007, 445(7125):319-323.
21. Kothlow S., Kaspers B. The avian respiratory immune system. Avian immunology 2008, 273-288. Academic Press, London. F. Davison, B. Kaspers (Eds.).
22. Luhtala M., Tregaskes C.A., Young J.R., Vainio O. Polymorphism of chicken CD8-alpha, but not CD8-beta. Immunogenetics 1997, 46(5):396-401.
23. Maas R., Tacken M., van Zoelen D., Oei H. Dose response effects of avian influenza (H7N7) vaccination of chickens: serology, clinical protection and reduction of virus excretion. Vaccine 2009, 27(27):3592-3597.
24. Mahmood M.S., Siddique M., Hussain I., Khan A., Mansoor M.K. Protection capability of recombinant plasmid DNA vaccine containing VP2 gene of very virulent infectious bursal disease virus in chickens adjuvanted with CpG oligodeoxynucleotide. Vaccine 2006, 24(22):4838-4846.
25. Marrack P., McKee A.S., Munks M.W. Towards an understanding of the adjuvant action of aluminium. Nat Rev Immunol 2009, 9(4):287-293.
26. Mast J., Goddeeris B.M., Peeters K., Vandesande F., Berghman L.R. Characterisation of chicken monocytes, macrophages and interdigitating cells by the monoclonal antibody KUL01. Vet Immunol Immunopathol 1998, 61(2-4):343-357.
27. Mast J., Goddeeris B.M. Development of immunocompetence of broiler chickens. Vet Immunol Immunopathol 1999, 70(3-4):245-256.
28. McGill J., Heusel J.W., Legge K.L. Innate immune control and regulation of influenza virus infections. J Leukoc Biol. 2009, 86(4):803-812.
29. Murthy T.R., Dorairajan N., Balasubramaniam G.A., Dinakaran A.M., Kalaimathi R. The effect of vaccination of pullets against Ornithobacterium rhinotracheale infection. Avian Pathol 2007, 36(6):481-485.
30. Pennings J.L., Kimman T.G., Janssen R. Identification of a common gene expression response in different lung inflammatory diseases in rodents and macaques. PLoS One 2008, 3(7):e2596.
31. Perrone L.A., Plowden J.K., García-Sastre A., Katz J.M., Tumpey T.M. H5N1 and 1918 pandemic influenza virus infection results in early and excessive infiltration of macrophages and neutrophils in the lungs of mice. PLoS Pathog 2008, 4(8):e1000115.
32. Reemers S.S., van Haarlem D.A., Groot Koerkamp M.J., Vervelde L. Differential gene expression and host response profiles against avian influenza virus within the chicken lung due to anatomy and airflow. J Gen Virol 2009, 90(Pt 9):2134-2146.
33. Reemers S.S., Groot Koerkamp M.J., Holstege F.C., van Eden W., Vervelde L. Cellular host transcriptional responses to Influenza A virus in chicken tracheal organ cultures differ from response in in vivo infected trachea. Vet Immunol Immunopathol 2009, 132(2-4):91-100.
34. Rimmelzwaan G.F., McElhaney J.E. Correlates of protection: novel generations of influenza vaccines. Vaccine 2008, 26(Supp. 4):D41-D44.
35. Sasaki T., Kokumai N., Ohgitani T., Sakamoto R., Takikawa N., Lin Z., et al. Long lasting immunity in chickens induced by a single shot of influenza vaccine prepared from inactivated non-pathogenic H5N1 virus particles against challenge with a highly pathogenic avian influenza virus. Vaccine 2009, 27(38):5174-5177.
36. Silvestri G., Sodora D.L., Koup R.A., Paiardini M., O'Neil S.P., McClure H.M., et al. Non-pathogenic SIV infection of sooty mangabeys is characterized by limited bystander immunopathology despite chronic high-level viremia. Immunity 2003, 18(3):441-452.
37. Tritto E., Mosca F., De Gregorio E. Mechanism of action of licensed vaccine adjuvants. Vaccine 2009, 27(25-26):3331-3334.
38. Vervelde L., Vermeulen A.N., Jeurissen S.H. In situ characterization of leucocyte subpopulations after infection with Eimeria tenella in chickens. Parasite Immunol 1996, 18(5):247-256.
39. Withers D.R., Young J.R., Davison T.F. Infectious bursal disease virus induced immunosuppression in the chick is associated with the presence of undifferentiated follicles in the recovering bursa. Viral Immunol 2005, 18(1):127-137.